Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Tam

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Nature Cell Biology|January 15, 2002
Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner HippiFrançois G Gervais, Roshni Singaraja, Steven Xanthoudakis, et al.
Science Advances|July 8, 2016
Exopolysaccharide biosynthetic glycoside hydrolases can be utilized to disrupt and prevent Pseudomonas aeruginosa biofilmsPerrin Baker, Preston J Hill, Brendan D Snarr, et al.
Microbiology Spectrum|April 26, 2023
Small Molecule Inhibition of an Exopolysaccharide Modification Enzyme is a Viable Strategy To Block Pseudomonas aeruginosa Pel Biofilm FormationErum Razvi, Benjamin R DiFrancesco, Gregory A Wasney, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
Nicotinyl aspartyl ketones as inhibitors of caspase-3Elise Isabel, W Cameron Black, Christopher I Bayly, et al.
Influenza and Other Respiratory Viruses|September 17, 2013
Vaccination of healthcare workers to protect patients at increased risk of acute respiratory disease: summary of a systematic reviewGayle P Dolan, Rebecca C Harris, Mandy Clarkson, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2005
Lipophilic versus hydrogen-bonding effect in P3 on potency and selectivity of valine aspartyl ketones as caspase 3 inhibitorsChristophe Mellon, Reneé Aspiotis, Cameron W Black, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2007
Solid-phase analogue synthesis of caspase-3 inhibitors via palladium-catalyzed amination of 3-bromopyrazinonesElise Isabel, Renee Aspiotis, W Cameron Black, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2025
De novo design of potent inhibitors of clostridial family toxinsRobert J Ragotte, Huazhu Liang, John Tam, et al.
British Journal of Pharmacology|January 28, 2004
Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's diseaseSylvie Toulmond, Keith Tang, Yves Bureau, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)Elaine H Lim, Shen-Li Zhang, Jia-Liang Li, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Nature Cell Biology|January 15, 2002
Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner HippiFrançois G Gervais, Roshni Singaraja, Steven Xanthoudakis, et al.
Science Advances|July 8, 2016
Exopolysaccharide biosynthetic glycoside hydrolases can be utilized to disrupt and prevent Pseudomonas aeruginosa biofilmsPerrin Baker, Preston J Hill, Brendan D Snarr, et al.
Microbiology Spectrum|April 26, 2023
Small Molecule Inhibition of an Exopolysaccharide Modification Enzyme is a Viable Strategy To Block Pseudomonas aeruginosa Pel Biofilm FormationErum Razvi, Benjamin R DiFrancesco, Gregory A Wasney, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
Nicotinyl aspartyl ketones as inhibitors of caspase-3Elise Isabel, W Cameron Black, Christopher I Bayly, et al.
Influenza and Other Respiratory Viruses|September 17, 2013
Vaccination of healthcare workers to protect patients at increased risk of acute respiratory disease: summary of a systematic reviewGayle P Dolan, Rebecca C Harris, Mandy Clarkson, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2005
Lipophilic versus hydrogen-bonding effect in P3 on potency and selectivity of valine aspartyl ketones as caspase 3 inhibitorsChristophe Mellon, Reneé Aspiotis, Cameron W Black, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2007
Solid-phase analogue synthesis of caspase-3 inhibitors via palladium-catalyzed amination of 3-bromopyrazinonesElise Isabel, Renee Aspiotis, W Cameron Black, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2025
De novo design of potent inhibitors of clostridial family toxinsRobert J Ragotte, Huazhu Liang, John Tam, et al.
British Journal of Pharmacology|January 28, 2004
Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's diseaseSylvie Toulmond, Keith Tang, Yves Bureau, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)Elaine H Lim, Shen-Li Zhang, Jia-Liang Li, et al.
Pageof 5